Juan Carlos Tinoco, MD

Hospital General de Durango, Mexico

Disclosure(s): GSK: Grant/Research Support

Poster(s):

• 114 - Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET